Conjugated Estrogen Cream (Premarin®)

Pre-clinicalCompleted
0 watching 0 views this week💤 Quiet
22
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Postmenopause

Conditions

Postmenopause

Trial Timeline

Sep 1, 2005 → Oct 1, 2006

About Conjugated Estrogen Cream (Premarin®)

Conjugated Estrogen Cream (Premarin®) is a pre-clinical stage product being developed by Pfizer for Postmenopause. The current trial status is completed. This product is registered under clinical trial identifier NCT00484107. Target conditions include Postmenopause.

Hype Score Breakdown

Clinical
5
Activity
2
Company
9
Novelty
2
Community
1

Clinical Trials (1)

NCT IDPhaseStatus
NCT00484107Pre-clinicalCompleted